SINTX Enters the $1.3B Foot and Ankle Implants Market with SiNAPTIC Acquisition
SINTX acquires SiNAPTIC assets, targeting the $1.3B foot and ankle fusion implant market.
Read More
Category: Dealstreet
Revolution Medicines Secures Powerhouse $2B Funding in Groundbreaking Royalty Pharma Deal
Revolution inks $2B flexible deal with Royalty Pharma to fund RAS(ON) inhibitors in cancer.
Read More
Alexion Strikes Bold AI Partnership for Rare Disease Detection
AI partnership targets rare bone disease affecting 1 in 6,000 patients.
Read MoreOwens & Minor Scraps $1.4B Rotech Deal Amid FTC Opposition
Medical distributor abandons home healthcare consolidation play.
Read More
Stryker Acquires Inari Medical: Strategic Expansion into Peripheral Vascular Treatment Market
Stryker Completes $3.1 Billion Acquisition of Inari Medical, Entering High-Growth Venous...
Read More